M
any studies have examined nitric oxide (NO)-dependent vasodilation and demonstrated changes in the endothelial function under pathophysiological conditions. [1] [2] [3] Acute pressure overload of the left ventricle (LV) and the coronary circulation could occur in various pathological as well as physiological states. Continuous arterial pressure recordings from normal subjects and hypertensive patients show variations of Ͼ50 mm Hg in mean systolic blood pressure (BP) occurring repeatedly throughout the day, 4 and increases in BP to Ͼ200 mm Hg have been reported during static exercise. 5 In addition, patients with malignant hypertension have acute increases in BP to Ͼ200 mm Hg. However, few studies have examined the effect of acute pressure overload on the endothelial function in coronary arteries. Recently, Higashi et al 6 reported that patients with renovascular hypertension and activation of the systemic renin-angiotensin system (RAS) have impaired forearm endothelial function, which is improved by renal-artery angioplasty through a reduction in oxidative stress. Because this observation was performed during systemic hypertension, it is hard to separate the effects of acute pressure overload itself (ie, mechanical force) on endothelial function from the effects of various systemic neurohumoral factors. Therefore, we examined the effects of acute pressure overload in the absence of systemic hypertension on endothelial function in the present study.
Endothelial function is controlled by a balance between the production of NO and oxygen (O 2 ) free radicals. 7, 8 In states in which NO production is not altered, its bioavailability may be reduced because of oxidative inactivation by excessive production of superoxide anion (O 2 Ϫ ) in the vascular wall. 9 Many studies have demonstrated that increased vascular production of O 2 Ϫ contributes to impaired endothelium-dependent vasodilation. 8, 10, 11 Angiotensin II (Ang II) may be generated in the various tissues in response to pressure overload. 12, 13 Ang II stimulation produces O 2 Ϫ through the activation of NAD(P)H oxidase in the endothelial cell 14 and vascular smooth muscle cell 15, 16 in vitro. We hypothesized that brief episodes of acute pressure overload lead to impairment of NO-dependent dilation, which is a result of the inactivation of NO by increased O 2 Ϫ , and the activation of NAD(P)H oxidase by Ang II plays an important role in these processes.
von-Bezold and Hirt 17 first reported that intravenous administration of veratrum alkaloids resulted in bradycardia and hypotension. The sensory receptors of the Bezold-Jarisch reflex are located in the LV of the heart, and the afferent and efferent arms of the Bezold-Jarisch reflex are vagal. 18, 19 Activation of ventricular receptors not only results in bradycardia and hypotension but also causes coronary vasodilation that is mediated by a cholinergic mechanism. 20 Our recent studies have indicated that the coronary vasodilation induced by activation of the Bezold-Jarisch reflex is NO dependent, because nitro-L-arginine, an NO synthase (NOS) inhibitor, blocks this coronary vasodilation. 2 Furthermore, vagally mediated coronary vasodilation is selectively impaired after pacing-induced heart failure 2 and enhanced after short-term exercise training 3 in conscious dogs in proportion to the altered release of NO from the vascular endothelium because of upregulation or downregulation of endothelial constitutive NOS (ecNOS). 21, 22 The goals of our in vivo experiments were to determine (1) whether brief episodes of acute pressure overload lead to impairment of NO-dependent coronary microvascular dilation after activation of the Bezold-Jarisch reflex and (2) the potential mechanism responsible. Because NO plays an important role in modulating myocardial O 2 consumption (MV O 2 ), which can be used as an in vitro bioassay for NO, we investigated the relationship between Ang II-induced O 2 Ϫ production and the NO-dependent control of MV O 2 . The goals of in vitro experiments were to determine (1) the effects of Ang II on MV O 2 regulation in LV tissues from normal dogs and (2) the role of increased O 2 Ϫ production.
Methods

Experiment 1
Surgical Preparation
Dogs (nϭ20; weight, 21 to 30 kg) were anesthetized, intubated, and ventilated. A thoracotomy was performed, and catheters for the aorta and left atrium, LV pressure gauge (P 6.5, Konigsberg Instruments Inc), a Doppler flow transducer (Craig Hartley), and a pair of pacing electrodes were instrumented as we described previously. 2, 3 A hydraulic occluder was implanted around the supravalvular ascending aorta to constrict the aorta (AOC). The dogs were allowed 10 to 14 days to recover fully and were trained to lie quietly on the laboratory 
Recording Techniques
Arterial pressure, LV pressure, and left circumflex coronary blood flow (CBF) were measured, heart rate (HR) was monitored, and mean arterial pressure (MAP) and mean CBF were derived as we described previously. 2, 3 Mean coronary resistance (CR) was calculated as the quotient of mean arterial pressure and CBF.
Experimental Protocols
Effects of AOC on Activation of Bezold-Jarisch Reflex by Veratrine.
In conscious dogs (nϭ20), veratrine at a dose of 5 g/kg was administered as a bolus injection (1 mL) into the left atrium through the implanted catheter with HR constant (150 bpm Five to 7 days later, ascorbic acid (nϭ5), losartan (nϭ5), or apocynin (nϭ4) was infused intravenously. Ascorbic acid was administered at an initial dose of 2000 mg, followed by a constant infusion at 25 mg/min at 90 minutes before AOC. Losartan was administered at a dose of 10 mg/kg over a period of 30 minutes and apocynin at a dose of 10 mg/kg over a period of 2 hours. Ascorbic acid was used as the antioxidant, losartan as Ang II type 1 (AT 1 ) receptor antagonist, and apocynin as an inhibitor of NAD(P)H oxidase activation. These doses were chosen on the basis of the previous data, 6, 10, 11, 23, 24 and the above-described protocols were repeated.
NO Production From Coronary Microvessels
Dogs were killed at 10 minutes after release of AOC (AOC dog), and coronary microvessels were isolated by the method of Zhang et al. 25 NO production stimulated by acetylcholine (ACh) or bradykinin (BK) was measured in coronary microvessels. The formation of NO was measured as nitrite by use of the Griess reaction. These results were compared with the results from dogs chronically instrumented but never having undergone AOC.
Experiment 2
Measurement of MV O 2 in Cardiac Muscle Segments
The preparation of LV cardiac muscle segments and the measurement of MV O 2 were as described previously. 25 Muscle segments were incubated with 10 Ϫ10 to 10 Ϫ8 mol/L Ang II 30 minutes before measurements of MV O 2 . In separate experiments, the effects of 10 Ϫ8 mol/L Ang II on MV O 2 were also studied in the presence of 10 Ϫ2 mol/L ascorbic acid, 10 Ϫ3 mol/L 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (tempol), 10 Ϫ6 mol/L losartan, or 10 Ϫ5 mol/L apocynin.
Inhibition of MV O 2 by BK and Exogenous NO
BK stimulates kinin B 2 -receptor on the endothelium to stimulate NO production. S-Nitroso-N-acetylpenicillamine (SNAP) was used as an NO donor. After baselines were recorded, cumulative concentrations of BK or SNAP at 10 Ϫ7 to 10 Ϫ4 mol/L were added to the chambers. The effects of BK and SNAP on MV O 2 were expressed as percent change of baseline MV O 2 .
O 2 ؊ Production
The chemiluminescence elicited by O 2 Ϫ in the presence of lucigenin (5 mol/L) was measured in cardiac muscle segments from the same dog that was used for measurements of MV O 2 as described previously. 26 Muscle segments were incubated by 10 Ϫ8 mol/L Ang II 30 minutes before measurements of chemiluminescence. In separate experiments, the effects of 10 Ϫ8 mol/L Ang II on O 2 Ϫ production were also determined in the presence of 10
Ϫ3 mol/L tempol, 10 Ϫ6 mol/L losartan, or 10 Ϫ5 mol/L apocynin. Photon counting was used to quantify chemiluminescence.
Chemicals
Losartan was purchased from DuPont Pharmaceuticals. Other drugs were purchased from Sigma-Aldrich Co.
Data Analysis
All data are presented as meanϮSEM. In in vivo studies, the responses are the peak after administration of veratrine. The statis-
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tical significance of differences (the null hypothesis) was determined with Student's t test for each peak response, and differences between groups were determined with repeated-measures ANOVA. When the ratio of F values indicated a significant difference, significance was determined by Scheffé's test. The changes in NO stimulation from canine coronary microvessels were determined with Student's t test. Changes were considered significant at a value of PϽ0.05.
Results
Effects of Veratrine on the Coronary Circulation and Hemodynamics
The heart was paced at 150 bpm to avoid the effects of veratrine-induced bradycardia on CBF. Figure 1 shows a typical response of CBF to veratrine. Veratrine caused significant increases in CBF and significant decreases in CR (to 1.74Ϯ0.11 mm Hg · min Ϫ1 · mL Ϫ1 from 2.67Ϯ0.15 mm Hg · min Ϫ1 · mL
Ϫ1
). The changes in systemic hemodynamics and CBF induced by veratrine are shown in the Table.
Effects of Veratrine After AOC
AOC increased LVSP to 211Ϯ4 mm Hg. After release of AOC, the CBF and hemodynamics were not altered (Table) . Figure 1 shows marked decreases in the vasodilation to veratrine in the same dog 10 minutes after release of AOC. Veratrine caused significantly smaller increases in CBF and decreases in CR 10 minutes after release of AOC (Figure 2 , Table) . These responses to veratrine were reduced for 2 to 24 hours. We refer to the reduced vasodilation to veratrine after AOC as "endothelial stunning."
NO Production From Coronary Microvessels
Nitrite production in response to ACh and BK by coronary microvessels from AOC dogs (ACh 145, BK 80 pmol · mg Ϫ1 · min Ϫ1 , nϭ2) was not decreased compared with normal dogs (ACh 83Ϯ13, BK 72Ϯ6 pmol · mg Ϫ1 · min Ϫ1 , nϭ7). The NO production to both ACh and BK was blocked by N G -nitro-Larginine methyl ester (L-NAME).
Effects of Ascorbic Acid on the Responses to Veratrine After AOC
It is well known that O 2 Ϫ inactivates NO. 9 To test whether the endothelial stunning is caused by O 2 Ϫ , ascorbic acid was given to scavenge O 2 Ϫ . AOC increased LVSP to 204Ϯ2 mm Hg during ascorbic acid infusion. After AOC, the baseline systemic hemodynamics were not altered in the dogs with ascorbic acid, but CBF was increased (Table) . Ascorbic acid preserved the response of CBF to veratrine 10 minutes after AOC (Figure 3 ).
Effects of Losartan on the Responses to Veratrine After AOC
Ang II could be generated in the arterial wall in response to increased vascular wall tension (AOC). 12, 13 Ang II increases vascular oxidative stress. 16, 27 AOC increased LVSP to 209Ϯ1 mm Hg after infusion of losartan (PϭNS versus LVSP during AOC in control dogs). Losartan preserved the response of CBF to veratrine 10 minutes after AOC (Figure 3 ).
Effects of Apocynin on the Responses to Veratrine After AOC
Ang II stimulation produces O 2 Ϫ through the activation of NAD(P)H oxidase in the endothelial 14 and vascular smooth muscle cells. 15, 16 To test whether the endothelial stunning is associated with the activation of NAD(P)H oxidases, apocynin was given. 24 AOC increased LVSP to 204Ϯ7 mm Hg after infusion of apocynin. Apocynin prevented the reduced responses of CBF and CR to veratrine 10 minutes after AOC (Figures 3 and 4) . This effect of apocynin lasted for the entire duration of the experiments (Figure 4) . 
Effects of Ang II on MV O 2 in Tissue in
Effects of
Veratrine (5 g/kg) on the Hemodynamics and
O 2 ؊ Production by Ang II
Ang II resulted in significant increases in O 2 Ϫ production, which were inhibited by coincubation with BK, losartan, ascorbic acid, tempol, or apocynin ( Figure 6 ). This inhibitory effect of O 2 Ϫ production by BK disappeared with coincubation with L-NAME ( Figure 6 ).
Discussion
The most important finding of present study is that acute pressure overload by supravalvular AOC leads to impairment of NO-dependent coronary microvascular dilation. We refer to this phenomenon as endothelial "stunning" because of the transient nature of this response. Nitrite production from coronary microvessels was not decreased at the time of endothelial stunning. Most importantly, the endothelial stunning was prevented by preadministration of ascorbic acid, losartan, or apocynin. Therefore, the endothelial stunning we observed in vivo was associated with increased O 2 Ϫ , which was mediated by increased Ang II-induced activation of NAD(P)H oxidase. Moreover, Ang II stimulation at pathophysiological concentration increased O 2 Ϫ through the activation of NAD(P)H oxidase and inhibited NO-dependent control of MV O 2 in cardiac tissues from normal dogs.
Acute hypertension (190 to 200 mm Hg in mean arterial BP) during intravenous norepinephrine administration leads to the appearance of O 2 Ϫ in the cerebral extracellular space and abolition of endothelium-dependent vascular relaxation of cerebral arterioles to ACh in anesthetized cat. 28 These effects were prevented by SOD. Patients with renovascular hypertension and activation of the RAS have impaired endothelium-mediated forearm vasodilation, which is improved by renal-artery angioplasty and reduced oxidant stress. 6 Furthermore, infusion of ascorbic acid improved the endothelial function in renovascular hypertension before angioplasty. 6 However, because these studies were performed in patients with renin-dependent hypertension, it is hard to separate the effects of mechanical force on endothelial function from the effects of various neurohumoral factors. Lamping and Dole 29 showed that acute elevations of coronary perfusion pressure for 15 minutes increased the constrictor response of large epicardial coronary arteries to serotonin. With this in mind, we examined the effects of acute pressure overload on coronary microvascular endothelial function in conscious dogs. Acute pressure overload increased LVSP to 200 mm Hg in our study but did not increase systemic pressure and HR. This suggests that the RAS and sympathetic nervous system were not systematically activated in our model. Ghaleh et al 30 showed that mean arterial pressure and HR were not increased and plasma renin was not activated even in conscious dogs with supravalvular aortic banding for 10 months.
Our results showed that reflex cholinergic coronary vasodilation after activation of the Bezold-Jarisch reflex was selectively depressed in conscious dogs after release of AOC.
The abnormalities in vagally mediated coronary vasodilation after release of AOC could be present at the cardiac receptor level, in the afferent nerves, in the central nervous system, or in the efferent nerves. This is most likely not the case, however, because reflex hypotension was still preserved. The coronary vasodilation induced by activation of the BezoldJarisch reflex is NO dependent, because nitro-L-arginine, an NOS inhibitor, blocks such coronary vasodilation. 2 Furthermore, vagally mediated coronary vasodilation is selectively impaired after pacing-induced heart failure 2 or enhanced after short-term exercise training in conscious dogs. 3 The changes in reflex cholinergic NO-dependent coronary vasodilation were proportional to the altered release of NO from the vascular endothelium because of altered gene expression of ecNOS. We examined NO production from coronary microvessels in response to ACh, but there were no changes. This suggests that the endothelial stunning is not a result of the effects of altered muscarinic receptor function. Furthermore, we also used another agonist, BK, whose effect is not mediated by muscarinic receptors to stimulate the release of NO from the endothelium. Again, there were no changes in NO production. Therefore, the endothelial stunning we observed is not because of altered NO production or the altered function of receptors mediating release of NO. O 2 Ϫ production by vascular tissues and its interaction with NO play important roles in vascular pathophysiology. 7, 8 O 2 Ϫ reacts rapidly with NO, reducing NO bioactivity, producing the oxidant peroxynitrite. 9 Therefore, we examined the effects of ascorbic acid on the endothelial stunning. Ascorbic acid prevented the endothelial stunning, perhaps directly scavenging O 2 Ϫ and thereby decreasing NO inactivation and inactivation of target enzymes. 6 33 or NO (1.9ϫ10 10 mol · L Ϫ1 · s Ϫ1 ). 34 Therefore, for ascorbic acid to prevent the interaction between O 2 Ϫ and NO, its concentration must exceed that of NO by a factor of 10 5 . It has been shown that in vitro ascorbic acid prevents this interaction when present in millimolar concentrations. 35 Ascorbic acid was infused intravenously at an initial dose of 2000 mg followed by a constant infusion at 25 mg/min in the present study. It is estimated that a plasma concentration of 10 Ϫ2 mol/L ascorbic acid is achieved in vivo by our method. 10 
Furthermore, O 2
Ϫ generated from intracellular sources is scavenged primarily within cells, because O 2 Ϫ is poorly transported across membranes. The intracellular concentration of ascorbic acid is increased in concentration-and time-dependent manners as its extracellular concentration is increased. 36 Because ascorbic acid was infused for 90 minutes before AOC in the present study, a sufficient intracellular concentration might be achieved to scavenge O 2 Ϫ within cell. Wung et al, 37 using human umbilical vein endothelial cells, showed that cyclic strain induced O 2 Ϫ . In this study, when the endothelial cells were exposed to cyclic strain for 30 minutes, intracellular O 2 Ϫ was increased. Furthermore, Hishikawa and Luscher 38 found that pulsatile stretch for 1 hour increased O 2 Ϫ production from human aortic endothelial cells, and this was reduced by diphenyleneiodonium chloride, an NADPH oxidase inhibitor. These in vitro studies using cultured endothelial cells support our data. We have not measured O 2 Ϫ directly at the time of endothelial stunning, but these data strongly suggest that the endothelial stunning induced by acute pressure overload is a result of NO inactivation subsequent to mechanical stretch-induced O 2 Ϫ production from the coronary microvessel endothelial cells.
Components of the RAS have been demonstrated in various tissues in the heart. 13 Increased gene transcript levels for renin, angiotensinogen, angiotensin receptors, and ACE have been identified in an experimental model of pressure overload. 13 Ang II stimulation produces O 2 Ϫ via AT 1 receptors and activation of NAD(P)H oxidases in endothelial 14 and vascular smooth muscle cells. 15, 16 Zhang et al 27 have shown that a pathophysiological level of Ang II impairs NO-dependent dilation in isolated porcine coronary arterioles, which is a result of elevated O 2 Ϫ production via AT 1 receptor activation of NAD(P)H oxidase. Therefore, we examined the effects of losartan and apocynin on endothelial stunning. Both losartan and apocynin entirely prevented endothelial stunning. These results suggest that increased O 2 Ϫ is responsible for endothelial stunning after AOC and that this is mediated by increased Ang II-induced activation of NAD(P)H oxidase.
In addition to vasodilation, NO derived from endothelium is of significance in the modulation of tissue O 2 consumption. NO decreases mitochondrial respiration and tissue respiration through the reversible inhibition of cytochrome c oxidase, complex IV of the mitochondrial electron transport chain. 39 Ϫ8 mol/L) of Ang II we used in the present study are the same as those used in previous reports in cultured cells. 14 -16 We do not know exactly whether the concentrations of Ang II we used in vitro experiments are attained in the coronary microcirculation after AOC in our in vivo model, but the estimated pathological plasma concentration of Ang II is 10 Ϫ10 mol/L, 41 and the interstitial level of Ang II may be more than 100 times that of plasma.
The vascular NAD(P)H oxidase is composed of both cytosolic and membrane-bound components. Combinations of the cytosolic p47phox, p67phox, and rac-1 associate, translate to, bind, and activate the membrane-bound complex composed of the p22phox and gp91phox subunits. 42 Cytosolic subunit binding is thought to enhance the conversion of molecular oxygen to O 2 Ϫ . Apocynin has been shown to prevent the binding of the cytosolic subunits of the NAD(P)H oxidase to the membrane-bound p22phox/Nox or gp91phox subunits, preventing oxidase activation and subsequent production of O 2 Ϫ in coronary artery. 43 The amount of apocynin we used in this in vivo experiment could prevent O 2 Ϫ production by activation of NAD(P)H oxidase. 24 Acute transient pressure overload for LV and coronary circulation occurs during stress and malignant hypertension. 4, 5 The results of the present study suggest that an acute transient increase in pressure might lead to coronary endothelial stunning. Furthermore, repeated episodes of acute transient increases in pressure might lead to the irreversible endothelial dysfunction. The relationship between Ang IIinduced O 2 Ϫ production and the NO-dependent control of MV O 2 remains unknown. In the present study, we showed that pathophysiological concentrations of Ang II inhibited the NO-dependent control of MV O 2 . These effects of Ang II might be one of the mechanisms responsible for the development of cardiac dysfunction.
In summary, the present results demonstrate that (1) the coronary vasodilation after activation of the Bezold-Jarisch reflex is depressed in conscious dogs after a brief episode of acute pressure overload; (2) the endothelial stunning we observed is associated with increased O 2 Ϫ , mediated by increased Ang II-induced activation of NAD(P)H oxidase; and (3) pathophysiological concentrations of Ang II increase O 2 Ϫ in the heart, which inhibits NO-dependent control of myocardial oxygen consumption.
